Hugh S Markus: nothing to disclose Poster session I - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.07 - SMALL VESSEL DISEASE P329 - ESOC25-1687 CHOLINERGIC DISRUPTION CONTRIBUTES TO MOTORIC COGNITIVE DYSFUNCTION IN CEREBRAL SMALL VESSEL DISEASE Mengfei Cai 1,2 , Hao Li 1 , Milan Nemy 3,4 , Mina Jacob 1 , David Norris 5 , Marco Duering 6 , Yuhu Zhang 2 , Roy Kessels 5 , Lenka Vyslouzilova 4 , Stefan Teipel 7 , Daniel Ferreira Padilla 3,8 , Frank-Erik De Leeuw 1 , Anil Tuladhar 1 1 Department of Neurology, RadboudUMC, Nijmegen, Netherlands, 2 Guangdong Provincial Peoples Hospital (Guangdong Academy of Medical Sciences), Guangzhou, Netherlands, 3 Karolinska Institute, Stockholm, Sweden, 4 Czech Technical University in Prague, Prague, Czech Republic, 5 Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands, 6 University of Basel, Basel, Switzerland, 7 Rostock University Medical Center, Rostock, Germany, 8 Universidad Fernando Pessoa Canarias, Las Palmas, Spain Background and Aims: Cerebral small vessel disease (SVD) is a key vascular contributor to both cognitive and motor dysfunction, consequently leading to an increased risk of dementia, parkinsonism, and loss of functional independence
FTCM does not accept responsibility for the tax treatment of any investment product
Rho Liposomal Glutathione is designed to work well with other recovery and performance supplements
MK-677 (Ibutamoren), (10mg/capsule) 60 Capsules Same Trusted Formula
